查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614339

药品契约製造市场：按产品、最终用户划分 - 2025-2030 年全球预测

Fill-finish Pharmaceutical Contract Manufacturing Market by Product (Consumables, Instruments), End-users (Academic Research Institutions, Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药品契约製造市场规模为104.7亿美元，预计2024年将达到113.8亿美元，复合年增长率为9.28%，预计到2030年将达到194.9亿美元。

药品契约製造是指药品製造过程最后阶段的外包，即药品被填充到管瓶和注射器等容器中并包装以进行分销。由于其资源密集和监管性质，这项服务至关重要，并且对于内部管理能力有限的小型企业或组织来说可能很困难。灌装-加工服务的最终用途应用包括製药公司、生技公司和医疗保健组织。市场的关键成长要素包括生技药品和生物相似药产量的增加、注射剂需求的成长、个人化医疗的进步以及推动先进药物输送系统的慢性病盛行率的上升。最近的技术进步，例如填充-加工作业的自动化和包装材料的创新，为製造商提供了提高效率和降低污染风险的潜在机会。为了利用这一点，公司应该专注于扩展其复杂配方的能力并投资于永续的包装解决方案。然而，高营运成本、严格的监管要求以及对专业设施的需求等挑战可能会阻碍市场成长。此外，由于全球供应链面临挑战，COVID-19 大流行造成的干扰仍然令人担忧。创新领域包括开发环保製造流程、将数位追踪技术整合到灌装和涂饰作业中，以及加强品质保证以提高准确性和安全性。市场动态是一个充满活力的市场，其特点是竞争激烈、技术进步迅速，持续的研发投资和产能扩张对于持续成长至关重要。与生物技术创新者合作并实施适应性强的製造解决方案对于未来的市场领导地位至关重要。

主要市场统计
基准年[2023] 104.7亿美元
预计年份 [2024] 113.8亿美元
预测年份 [2030] 194.9亿美元
复合年增长率（%） 9.28%

市场动态：揭示快速发展的药品契约製造市场的关键市场洞察

药品契约製造市场正在因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 生物製药核准数量增加
    • 技术进步和填充加工製造流程外包的增加
    • 扩大多产品导向设施的使用
  • 市场限制因素
    • 服务成本上升及监管环境复杂
  • 市场机会
    • 更多采用自动化和机器人技术，以提高填充完成表面处理工程的效率、准确性和安全性
    • 越来越多地转向支持个人化医疗的灵活製造系统
  • 市场挑战
    • 与维持相关生产设施无菌相关的技术问题

波特五力：驾驭药品契约製造市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药品契约製造市场的外部影响

外部宏观环境因素在塑造药品契约製造市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解药品契约製造市场的竞争状况

药品契约製造市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 医药契约製造市场中的定位矩阵供应商绩效评估

FPNV定位矩阵是评估药品契约製造市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘药品契约製造市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，药品契约製造市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生物製药核准数量增加
      • 填充和表面处理製造流程和外包方面的技术不断进步
      • 扩大多产品设施的使用
    • 抑制因素
      • 高成本和复杂的监管环境
    • 机会
      • 扩展自动化和机器人技术，以提高填充和表面处理工程的效率、准确性和安全性
      • 更多转向个人化医疗的灵活製造系统
    • 任务
      • 与维持相关生产设施无菌相关的技术问题
  • 市场区隔分析
    • 产品：填充和精整操作仪器的进步
    • 最终用户：製药和生物製药公司的各种应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药品契约製造市场：副产品

  • 消耗品
    • 安瓿
    • 瓶子
    • 墨水匣
    • IVs
    • 预填充式注射器
    • 管瓶
  • 装置
    • 机器类型
    • 系统
      • 综合系统
      • 独立系统

第七章 药品契约製造市场：依最终用户分类

  • 学术研究所
  • 契约製造组织
  • 製药和生物製药公司
  • 研发机构

第 8 章：美洲药品契约製造市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太药品契约製造市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲药品契约製造市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 斯蒂瓦那托集团推出 EZ 填充套件以及实验室填充和精加工服务
    • Cytovance Biologics 和 Alcami 合作优化无菌填充和精加工操作
    • 三星生物製品公司和 Kuruma Partners 宣布建立策略合作伙伴关係，为 Kuruma 投资组合公司开发和製造生技药品
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Ajinomoto Bio-Pharma Services
  • Argonaut Manufacturing Services
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent Inc.
  • Chemtech International, Inc.
  • Eurofins Scientific SE
  • Federal Equipment Company
  • Fresenius Kabi Contract Manufacturing
  • GBI Biomanufacturing
  • Gerresheimer AG
  • Grand River Aseptic Manufacturing
  • Groninger & Co. GmbH
  • Jubilant HollisterStier CMO
  • MabPlex International Co. Ltd.
  • Novartis AG
  • OPTIMA Packaging Group GmbH
  • Pfizer Inc.
  • Piramal Pharma Solutions
  • Recipharm AB
  • Societal CDMO
  • Syngene International Ltd.
  • Syntegon Pharma Technology
  • Vetter Pharma International
Product Code: MRR-0D217D5B027E

The Fill-finish Pharmaceutical Contract Manufacturing Market was valued at USD 10.47 billion in 2023, expected to reach USD 11.38 billion in 2024, and is projected to grow at a CAGR of 9.28%, to USD 19.49 billion by 2030.

Fill-finish pharmaceutical contract manufacturing refers to the outsourcing of the final steps in the pharmaceutical production process, where drug products are filled into vials, syringes or other containers, and packaged for distribution. This service is critical due to its resource-intensive and regulatory-compliant nature, which smaller companies or organizations with limited capacity may struggle to manage in-house. The application scope of fill-finish services is broad, covering biologics, vaccines, and other injectables, with end-use domains spanning across pharmaceutical companies, biotechnology firms, and healthcare institutions. Key growth influences in this market include the increasing production of biologics and biosimilars, growing demand for injectables, advancement in personalized medicine, and the rising prevalence of chronic diseases that push for sophisticated drug delivery systems. Recent technological advancements, such as automation in fill-finish operations, and innovation in packaging materials, present potential opportunities for manufacturers to enhance efficiency and reduce contamination risks. To capitalize, companies should focus on expanding capabilities to accommodate complex formulations and invest in sustainable packaging solutions. However, challenges such as high operational costs, stringent regulatory requirements, and the need for specialized facilities could hamper market growth. Further, the COVID-19 pandemic-induced disruptions remain a concern due to the global supply chain challenges. Areas ripe for innovation include development of eco-friendly manufacturing processes, integration of digital tracking technologies during fill-finish operations, and enhancements in quality assurance to augment precision and safety. The fill-finish pharmaceutical contract manufacturing market is dynamic, characterized by intense competition and rapid technological advancement, making continual investment in R&D and capacity expansion vital for sustaining growth. Embracing collaborations with biotech innovators and implementing adaptable manufacturing solutions are crucial for future market leadership.

KEY MARKET STATISTICS
Base Year [2023] USD 10.47 billion
Estimated Year [2024] USD 11.38 billion
Forecast Year [2030] USD 19.49 billion
CAGR (%) 9.28%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fill-finish Pharmaceutical Contract Manufacturing Market

The Fill-finish Pharmaceutical Contract Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of biologic drugs approval
    • Increasing technological advancements in fill-finish manufacturing processes and outsourcing
    • Growing usage of multi-product-use-oriented facilities
  • Market Restraints
    • High cost of services and complex regulatory landscape
  • Market Opportunities
    • Increasing adoption of automation and robotics to enhance efficiency, accuracy, and safety in fill-finish processes
    • Rising shift towards flexible manufacturing systems catering to personalized medicine
  • Market Challenges
    • Technical issues related to maintaining sterility in associated manufacturing facility

Porter's Five Forces: A Strategic Tool for Navigating the Fill-finish Pharmaceutical Contract Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fill-finish Pharmaceutical Contract Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fill-finish Pharmaceutical Contract Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fill-finish Pharmaceutical Contract Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fill-finish Pharmaceutical Contract Manufacturing Market

A detailed market share analysis in the Fill-finish Pharmaceutical Contract Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fill-finish Pharmaceutical Contract Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fill-finish Pharmaceutical Contract Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fill-finish Pharmaceutical Contract Manufacturing Market

A strategic analysis of the Fill-finish Pharmaceutical Contract Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fill-finish Pharmaceutical Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Ajinomoto Bio-Pharma Services, Argonaut Manufacturing Services, Baxter International, Inc., Boehringer Ingelheim International GmbH, Catalent Inc., Chemtech International, Inc., Eurofins Scientific SE, Federal Equipment Company, Fresenius Kabi Contract Manufacturing, GBI Biomanufacturing, Gerresheimer AG, Grand River Aseptic Manufacturing, Groninger & Co. GmbH, Jubilant HollisterStier CMO, MabPlex International Co. Ltd., Novartis AG, OPTIMA Packaging Group GmbH, Pfizer Inc., Piramal Pharma Solutions, Recipharm AB, Societal CDMO, Syngene International Ltd., Syntegon Pharma Technology, and Vetter Pharma International.

Market Segmentation & Coverage

This research report categorizes the Fill-finish Pharmaceutical Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Ampoules, Bottles, Cartridges, IVs, Prefilled Syringes, and Vials. The Instruments is further studied across Machine Type and Systems. The Systems is further studied across Integrated Systems and Standalone Systems.
  • Based on End-users, market is studied across Academic Research Institutions, Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies, and Research & Development laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of biologic drugs approval
      • 5.1.1.2. Increasing technological advancements in fill-finish manufacturing processes and outsourcing
      • 5.1.1.3. Growing usage of multi-product-use-oriented facilities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of services and complex regulatory landscape
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing adoption of automation and robotics to enhance efficiency, accuracy, and safety in fill-finish processes
      • 5.1.3.2. Rising shift towards flexible manufacturing systems catering to personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Technical issues related to maintaining sterility in associated manufacturing facility
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Advancements in instrumentations for fill-finish operations
    • 5.2.2. End-users: Diverse applications in pharmaceutical & biopharmaceutical companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fill-finish Pharmaceutical Contract Manufacturing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Ampoules
    • 6.2.2. Bottles
    • 6.2.3. Cartridges
    • 6.2.4. IVs
    • 6.2.5. Prefilled Syringes
    • 6.2.6. Vials
  • 6.3. Instruments
    • 6.3.1. Machine Type
    • 6.3.2. Systems
      • 6.3.2.1. Integrated Systems
      • 6.3.2.2. Standalone Systems

7. Fill-finish Pharmaceutical Contract Manufacturing Market, by End-users

  • 7.1. Introduction
  • 7.2. Academic Research Institutions
  • 7.3. Contract Manufacturing Organizations
  • 7.4. Pharmaceutical & Biopharmaceutical Companies
  • 7.5. Research & Development laboratories

8. Americas Fill-finish Pharmaceutical Contract Manufacturing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Fill-finish Pharmaceutical Contract Manufacturing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Fill-finish Pharmaceutical Contract Manufacturing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Stevanato Group Launches EZ-fill Kit and Laboratory Fill and Finish Service
    • 11.3.2. Cytovance Biologics, Alcami Partner to Optimize Sterile Fill-Finish Ops
    • 11.3.3. Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma's portfolio companies
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Ajinomoto Bio-Pharma Services
  • 3. Argonaut Manufacturing Services
  • 4. Baxter International, Inc.
  • 5. Boehringer Ingelheim International GmbH
  • 6. Catalent Inc.
  • 7. Chemtech International, Inc.
  • 8. Eurofins Scientific SE
  • 9. Federal Equipment Company
  • 10. Fresenius Kabi Contract Manufacturing
  • 11. GBI Biomanufacturing
  • 12. Gerresheimer AG
  • 13. Grand River Aseptic Manufacturing
  • 14. Groninger & Co. GmbH
  • 15. Jubilant HollisterStier CMO
  • 16. MabPlex International Co. Ltd.
  • 17. Novartis AG
  • 18. OPTIMA Packaging Group GmbH
  • 19. Pfizer Inc.
  • 20. Piramal Pharma Solutions
  • 21. Recipharm AB
  • 22. Societal CDMO
  • 23. Syngene International Ltd.
  • 24. Syntegon Pharma Technology
  • 25. Vetter Pharma International

LIST OF FIGURES

  • FIGURE 1. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY IVS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MACHINE TYPE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY RESEARCH & DEVELOPMENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 237. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023